Latest Innovation And Technology News

Locksley Resources has raised A$17 million in an oversubscribed placement led by U.S. institutional investors, accelerating its strategy to develop a domestic supply chain for antimony and rare earths in California.

Identitii Limited launches a $2.9 million rights issue, underwritten up to $2.3 million by its largest shareholder, to accelerate the commercial rollout of its BNDRY platform.

Volt Resources has initiated a Definitive Feasibility Study for its Alabama Graphite Refinery, aiming to produce high purity graphite by mid-2026 and strengthen US critical minerals supply chains.

Environmental Clean Technologies Limited has appointed renowned PFAS litigation expert Robert Bilott to its Advisory Board, aiming to accelerate commercialisation of its innovative remediation technology. This strategic move coincides with shareholder approval of ECT’s acquisition of Terrajoule Pty Ltd.

Uscom Limited reported a 25% revenue decline in FY25 amid global geopolitical challenges but reinforced its commitment to growth through strategic partnerships and innovative medical technologies.

Audeara Limited has achieved a key regulatory milestone with NMPA certification in China, paving the way for commercial launch of its hearing personalisation technology through a leading e-commerce brand. This approval supports the company’s strategy to generate scalable licensing revenue in a rapidly growing market.

Critical Resources Limited has significantly expanded its Mavis Lake Lithium Project in Ontario, boosting its landholding by 25% and advancing exploration with promising high-grade lithium intercepts. The company also secured a strategic partnership to evaluate cutting-edge solid-state lithium-ion battery technology, positioning itself for the anticipated lithium market rebound.

Redivium Limited confirms a setback in securing its Wrexham recycling plant lease but maintains strong project fundamentals and explores innovative refining technology to boost UK battery material production.

CSIRO has sold about half its shares in Chrysos Corporation through a block trade, reducing its stake by roughly 9%, yet remains a committed substantial shareholder with a six-month escrow on its retained shares.

Parkway Corporate Limited has marked its transition to profitability in FY25, unveiling a transformative Queensland Brine Management Complex project set to redefine waste brine processing in Australia’s coal seam gas sector.

Osteopore Limited has drawn an additional A$250,000 under the first tranche of its redeemable convertible notes, continuing its steady capital raise to support growth and innovation.

Clarity Pharmaceuticals has raised $203 million to accelerate its copper-64 and copper-67 radiopharmaceutical pipeline, targeting prostate and neuroendocrine cancers with multiple FDA Fast Track trials underway.